Results 141 to 150 of about 367,294 (339)

Effect and Safety of Finerenone in Patients with IgA Nephropathy

Journal of Inflammation Research
Yanhong Guo,* Xuewen Zhang,* Silu Zhao,* Yulin Wang, Liuwei Wang, Qiuhong Li, Lu Yu, Lin Tang Department of Nephropathy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People’s Republic of China ...
Guo Y, Zhang X, Zhao S, Wang Y, Wang L, Li Q, Yu L, Tang L   +7 more
doaj  

Elevated ALOX12 in renal tissue predicts progression in diabetic kidney disease

Renal Failure
Diabetic kidney disease (DKD) is one of the major causes of end-stage renal disease and one of the significant complications of diabetes. This study aims to identify the main differentially expressed genes in DKD from transcriptome sequencing results and
Meixi Wang, Jingjing Wang, Jinni Wang, Yonggui Wu, Xiangming Qi   +4 more
doaj   +1 more source

Mesoamerican Nephropathy and Kidney Disease Progression: A Case Series of Individuals With Kidney Biopsies From Nicaragua and El Salvador

, 2021
Julia Wijkström, Marvin González-Quiroz, Ricardo Leiva, Zulma Trujillo, Carl‐Gustaf Elinder, Annika Wernerson   +5 more
openalex   +1 more source

ANALGESIC NEPHROPATHY [PDF]

Australian and New Zealand Journal of Medicine, 1968
openaire   +9 more sources

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source

Long-term prevention of diabetic nephropathy: an audit [PDF]

, 2008
K. J. Schjoedt, Henrik Post Hansen, Lise Tarnow, Peter Rossing, Hans‐Henrik Parving   +4 more
openalex   +1 more source

Targeting the Nrf2/TGF‐β1/Smad Signaling Pathway: A Novel Strategy for Urolithin A to Alleviate Renal Fibrosis

Food Frontiers, EarlyView.
The diagram of the mechanism of action by which UroA regulates RF. ABSTRACT The global prevalence and mortality rates associated with chronic kidney disease (CKD) have been on a continuous rise over recent decades. Renal fibrosis (RF) serves as a critical factor in the progression of CKD to end‐stage renal disease.
Xue Wu, Jiating Li, Yonghui Dong, Jia Li, Ji Bian, Chao Liu, Hongbo Zhang, Lin Han, Min Wang   +8 more
wiley   +1 more source

Tocotrienols: A Review From Source to Therapeutic Applications

Food Frontiers, EarlyView.
Tocotrienols demonstrate superior antioxidant, neuroprotective, and anti‐inflammatory properties compared to conventional vitamin E forms, with promising therapeutic applications across multiple disorders when delivered through optimized systems that enhance their inherently limited bioavailability.
Natalia‐Carolina Londoño, Nidia Casas‐Forero, Andres‐Felipe Garzón‐Méndez, Dalí‐Aleixandra Rojas‐Díaz, Mary‐Luz Olivares‐Tenorio, Hernan‐Mauricio Romero, Jesús‐Alberto García‐Núñez   +6 more
wiley   +1 more source

Membranous nephropathy with acquired factor V inhibitor: a case report [PDF]

, 2013
Shinji Kitamura, Mahito Misawa, S Namba, Kenji Tsuji, Rikako Torigoe, Midori Shima, Hirofumi Makino   +6 more
openalex   +1 more source

A vegetable oil blend administration mitigates the hyperglycemia-induced redox imbalance, renal histopathology, and function in diabetic nephropathy

, 2022
Sadaf Anwar, Mohd Adnan Kausar, Kehkashan Parveen, Waseem Ahmad Siddiqui, Aqeela Zahra, Abrar Ali, Riadh Badraoui, Azfar Jamal, Naseem Akhtar, Mοhd Saeed   +9 more
openalex   +1 more source